-RBCC has acquired a new equity interest in Nano3D Biosciences, Inc. (n3D).
-n3D's nanoparticle technology could completely revolutionize cell research.
-RBCC is spearheading the most innovative scientific and medical breakthroughs in the $84.6 billion global biotech industry.
-U.S. biotech companies raised $25 billion in 2010--a 15-percent jump over the previous year's investment total, according to Ernst & Young.
-RBCC is joining the ranks of bioscience companies like Puma-a company that recently announced a private placement of 14.7 million shares of its common stock to investors, resulting in proceeds of $55 million
My posts are my opinion and should not be used as investment advice. Always do your own DD.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.